The power and the promise of oncogene-induced senescence markers

Nature Reviews Cancer

Volumn 6, Issue 6, 2006, Pages 472-476

  Collado, Manuel ^a   Serrano, Manuel ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; BETA GALACTOSIDASE; PROTEIN P16INK4A; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CARCINOGENESIS; CHEMOSENSITIVITY; CHEMOTHERAPY; CIRCADIAN RHYTHM; DNA DAMAGE; DNA MICROARRAY; EPIGENETICS; HETEROCHROMATIN; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; REVIEW; SENESCENCE; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CASPASES; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 33745712849     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1884     Document Type: Review

References (51)

1. Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636 (1965).
2. Serrano, M. & Blasco, M. A. Putting the stress on senescence. Curr. Opin. Cell Biol. 13, 748-753 (2001).
3. Shay, J. W. & Roninson, I. B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23, 2919-2933 (2004).
4. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
5. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004).
6. Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665 (2005).
7. Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730 (2005).
8. Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642 (2005).
9. Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724 (2005).
10. Guerra, C. et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4, 111-120 (2003).
11. Tuveson, D. A. et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375-387 (2004).
12. Lo, T. L. et al. Sprouty and cancer: the first terms report. Cancer Lett. 6 Feb 2006 [epub ahead of print].
13. Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S. & Horii, A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 162, 1807-1815 (2003).
14. Hoornaert, I., Marynen, P., Goris, J., Sciot, R. & Baens, M. MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation. Oncogene 22, 7728-7736 (2003).
15. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
16. Kurz, D. J., Decary, S., Hong, Y. & Erusalimsky, J. D. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 113 , 3613-3622 (2000).
17. Severino, J., Allen, R. G., Balin, S., Balin, A. & Cristofalo, V. J. Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Exp. Cell Res. 257, 162-171 (2000).
18. Yang, N. C. & Hu, M. L. A fluorimetric method using fluorescein di-beta-D-galactopyranoside for quantifying the senescence-associated beta-galactosidase activity in human foreskin fibroblast Hs68 cells. Anal. Biochem. 325, 337-343 (2004).
19. Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522 (2005).
20. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
21. Ruas, M. & Peters, G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys. Acta. 1378, F115-F177 (1998).
22. Sharpless, N. E. & DePinho, R. A. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9, 22-30 (1999).
23. Lazzerini Denchi, E., Attwooll, C., Pasini, D. & Helin, K. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol. Cell. Biol. 25, 2660-2672 (2005).
24. Shapiro, G. I. et al. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55, 505-509 (1995).
25. Masumoto, N. et al. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum. Pathol. 34, 778-783 (2003).
26. Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003).
27. Zhang, R. et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8, 19-30 (2005).
28. Malumbres, M. et al. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol. Cell. Biol. 20, 2915-2925 (2000).
29. Nagane, M., Huang, H. J. & Cavenee, W. K. The potential of TRAIL for cancer chemotherapy. Apoptosis 6, 191-197 (2001).
30. Giatromanolaki, A. et al. DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J. Pathol. 200, 222-228 (2003).
31. Liu, X., Yue, P., Khuri, F. R. & Sun, S. Y. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer. Res. 65, 9169-9175 (2005).
32. Yamada, K. & Miyamoto, K. Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. Front. Biosci. 10, 3151-3171 (2005).
33. Barradas, M. et al. Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence. Exp. Cell Res. 273, 127-137 (2002).
34. Hama, T. et al. Identification and molecular cloning of a novel brain-specific receptor protein that binds to brain injury-derived neurotrophic peptide. Possible role for neuronal survival. J. Biol. Chem. 276, 31929-31935 (2001).
35. Brunk, U. T. & Terman, A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33, 611-619 (2002).
36. Gerland, L. M. et al. Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp. Gerontol. 38, 887-895 (2003).
37. Mu, X. C. & Higgins, P. J. Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts. J. Cell. Physiol. 165, 647-657 (1995).
38. Mason, D. X., Jackson, T. J. & Lin, A. W. Molecular signature of oncogenic ras-induced senescence. Oncogene 23, 9238-9246 (2004).
39. Chang, B. D. et al. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl Acad. Sci. USA 99, 389-394 (2002).
40. Schmitt, C. A. Senescence, apoptosis and therapy - cutting the lifelines of cancer. Nature Rev. Cancer. 3, 286-295 (2003).
41. Rebbaa, A., Zheng, X., Chou, P. M. & Mirkin, B. L. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22, 2805-2811 (2003).
42. Zheng, X., Chou, P. M., Mirkin, B. L. & Rebbaa, A. Senescence-initiated reversal of drug resistance: specific role of cathepsin L. Cancer Res. 64, 1773-1780 (2004).
43. te Poele, R. H., Okorokov, A. L., Jardine, L., Cummings, J. & Joel, S. P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62, 1876-1883 (2002).
44. Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S. Y. & Wu, D. Y. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res. 65, 2795-2803 (2005).
45. Sedelnikova, O. A. et al. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biol. 6, 168-170 (2004).
46. Shelton, D. N., Chang, E., Whittier, P. S., Choi, D. & Funk, W. D. Microarray analysis of replicative senescence. Curr. Biol. 9, 939-645 (1999).
47. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072-12077 (2001).
48. Alcorta, D. A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13742-13747 (1996).
49. Afshari, C. A. et al. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp. Cell Res. 209, 231-237 (1993).
50. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659 (1997).
51. Tahara, H., Sato, E., Noda, A. & Ide, T. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10, 835-840 (1995).